FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019188051> ?p ?o ?g. }

• W2019188051 endingPage "2648" @default.
• W2019188051 startingPage "2642" @default.
• W2019188051 abstract "BACKGROUND Alternative medicine therapies are estimated to be used by 7–64% of cancer patients but up to 72% do not inform their physician. To the authors' knowledge little useful information is available regarding the prevalence of alternative medicine use by patients with prostate carcinoma. Thus, the authors attempted to evaluate the prevalence of alternative medicine use by prostate carcinoma patients treated with curative intent by either radical prostatectomy, brachytherapy alone, or a combination of brachytherapy and external radiation therapy. METHODS Between January 1997 and May 1998, 234 men with clinically localized prostate carcinoma underwent radical prostatectomy (54 patients) or brachytherapy (180 patients) with (74 patients) or without (106 patients) external beam radiation therapy. In July 1998 a questionnaire was mailed to all patients comprised of multiple questions regarding alternative medicine use to which 190 patients (81%) responded. The overall prevalence and types of alternative medicine therapies used were assessed and the relation between age at procedure, pretreatment prostate specific antigen level, clinical stage, pretreatment Gleason score, and type of treatment with the use of alternative medicine therapies was evaluated using univariate and multivariate analysis. RESULTS The prevalence of alternative medicine use by prostate carcinoma patients responding to the survey was 43% (81 of 190 patients). No significant differences in alternative medicine use were observed between the patients who received brachytherapy alone (38%), those who underwent radical prostatectomy (40%), and those treated with combined brachytherapy and external beam radiation therapy (51%). Vitamins, prayer or other religious practices, and herbal medicines were the most commonly used therapies in these patients. Higher pretreatment Gleason scores were associated with a greater use of alternative medicine therapies on both multivariate and univariate analyses. Finally, using multivariate analysis, younger prostate carcinoma patients were more likely to use alternative medicine therapies than older patients. CONCLUSIONS Alternative medicine use is very prevalent among patients treated for localized prostate carcinoma. Because some of these treatments may have a potential biologic impact on tumor behavior and, consequently, on definitive or surrogate therapeutic endpoints, patients should be questioned carefully regarding alternative medicine use during routine tumor follow-up. Cancer 1999;86:2642–8. © 1999 American Cancer Society." @default.
• W2019188051 created "2016-06-24" @default.
• W2019188051 creator A5011037596 @default.
• W2019188051 creator A5020183452 @default.
• W2019188051 creator A5046545567 @default.
• W2019188051 creator A5066770760 @default.
• W2019188051 date "1999-12-15" @default.
• W2019188051 modified "2023-10-17" @default.
• W2019188051 title "Alternative medicine use in patients with localized prostate carcinoma treated with curative intent" @default.
• W2019188051 cites W1985866187 @default.
• W2019188051 cites W2006115709 @default.
• W2019188051 cites W2006945483 @default.
• W2019188051 cites W2010314100 @default.
• W2019188051 cites W2015890046 @default.
• W2019188051 cites W2026073973 @default.
• W2019188051 cites W2028168267 @default.
• W2019188051 cites W2028585120 @default.
• W2019188051 cites W2042366482 @default.
• W2019188051 cites W2084200547 @default.
• W2019188051 cites W2089279515 @default.
• W2019188051 cites W2095377270 @default.
• W2019188051 cites W2099730168 @default.
• W2019188051 cites W2101317665 @default.
• W2019188051 cites W2105523196 @default.
• W2019188051 cites W2111142720 @default.
• W2019188051 cites W2156176336 @default.
• W2019188051 cites W2157073178 @default.
• W2019188051 cites W2242969173 @default.
• W2019188051 cites W2334427329 @default.
• W2019188051 cites W2397558196 @default.
• W2019188051 cites W2887774508 @default.
• W2019188051 doi "https://doi.org/10.1002/(sici)1097-0142(19991215)86:12<2642::aid-cncr8>3.0.co;2-4" @default.
• W2019188051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10594859" @default.
• W2019188051 hasPublicationYear "1999" @default.
• W2019188051 type Work @default.
• W2019188051 sameAs 2019188051 @default.
• W2019188051 citedByCount "95" @default.
• W2019188051 countsByYear W20191880512012 @default.
• W2019188051 countsByYear W20191880512013 @default.
• W2019188051 countsByYear W20191880512016 @default.
• W2019188051 countsByYear W20191880512017 @default.
• W2019188051 countsByYear W20191880512018 @default.
• W2019188051 countsByYear W20191880512020 @default.
• W2019188051 crossrefType "journal-article" @default.
• W2019188051 hasAuthorship W2019188051A5011037596 @default.
• W2019188051 hasAuthorship W2019188051A5020183452 @default.
• W2019188051 hasAuthorship W2019188051A5046545567 @default.
• W2019188051 hasAuthorship W2019188051A5066770760 @default.
• W2019188051 hasBestOaLocation W20191880511 @default.
• W2019188051 hasConcept C121608353 @default.
• W2019188051 hasConcept C126322002 @default.
• W2019188051 hasConcept C126894567 @default.
• W2019188051 hasConcept C141071460 @default.
• W2019188051 hasConcept C143998085 @default.
• W2019188051 hasConcept C2775908122 @default.
• W2019188051 hasConcept C2776235491 @default.
• W2019188051 hasConcept C2777416452 @default.
• W2019188051 hasConcept C2777546739 @default.
• W2019188051 hasConcept C2779466945 @default.
• W2019188051 hasConcept C2780192828 @default.
• W2019188051 hasConcept C2781406297 @default.
• W2019188051 hasConcept C509974204 @default.
• W2019188051 hasConcept C71924100 @default.
• W2019188051 hasConceptScore W2019188051C121608353 @default.
• W2019188051 hasConceptScore W2019188051C126322002 @default.
• W2019188051 hasConceptScore W2019188051C126894567 @default.
• W2019188051 hasConceptScore W2019188051C141071460 @default.
• W2019188051 hasConceptScore W2019188051C143998085 @default.
• W2019188051 hasConceptScore W2019188051C2775908122 @default.
• W2019188051 hasConceptScore W2019188051C2776235491 @default.
• W2019188051 hasConceptScore W2019188051C2777416452 @default.
• W2019188051 hasConceptScore W2019188051C2777546739 @default.
• W2019188051 hasConceptScore W2019188051C2779466945 @default.
• W2019188051 hasConceptScore W2019188051C2780192828 @default.
• W2019188051 hasConceptScore W2019188051C2781406297 @default.
• W2019188051 hasConceptScore W2019188051C509974204 @default.
• W2019188051 hasConceptScore W2019188051C71924100 @default.
• W2019188051 hasIssue "12" @default.
• W2019188051 hasLocation W20191880511 @default.
• W2019188051 hasLocation W20191880512 @default.
• W2019188051 hasOpenAccess W2019188051 @default.
• W2019188051 hasPrimaryLocation W20191880511 @default.
• W2019188051 hasRelatedWork W1888477076 @default.
• W2019188051 hasRelatedWork W2032157250 @default.
• W2019188051 hasRelatedWork W2071879586 @default.
• W2019188051 hasRelatedWork W2120703505 @default.
• W2019188051 hasRelatedWork W2123312949 @default.
• W2019188051 hasRelatedWork W4206581437 @default.
• W2019188051 hasRelatedWork W4230379269 @default.
• W2019188051 hasRelatedWork W4255881101 @default.
• W2019188051 hasRelatedWork W42639213 @default.
• W2019188051 hasRelatedWork W2023475404 @default.
• W2019188051 hasVolume "86" @default.
• W2019188051 isParatext "false" @default.
• W2019188051 isRetracted "false" @default.
• W2019188051 magId "2019188051" @default.
• W2019188051 workType "article" @default.